Clinical Trial Update: Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity

View source ↗

Summary

This clinical trial aimed at identifying early biomarkers and understanding the pathogenesis of anthracycline-induced cardiotoxicity in pediatric cancer patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Connecticut Children's Medical Center | Conditions: Childhood Cancer | Status: WITHDRAWN